Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion

An immune correlates analysis of the RV144 HIV-1 vaccine trial revealed that antibody responses to the gp120 V1/V2 region correlated inversely with infection risk. The RV144 protein immunogens (A244-rp120 and MN-rgp120) were modified by an N-terminal 11-amino-acid deletion (Δ11) and addition of a he...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Alam, S. Munir, Liao, Hua-Xin, Tomaras, Georgia D., Bonsignori, Mattia, Tsao, Chun-Yen, Hwang, Kwan-Ki, Chen, Haiyan, Lloyd, Krissey E., Bowman, Cindy, Sutherland, Laura, Jeffries, Thomas L., Kozink, Daniel M., Stewart, Shelley, Anasti, Kara, Jaeger, Frederick H., Parks, Robert, Yates, Nicole L., Overman, R. Glenn, Sinangil, Faruk, Berman, Phillip W., Pitisuttithum, Punnee, Kaewkungwal, Jaranit, Nitayaphan, Sorachai, Karasavva, Nicos, Rerks-Ngarm, Supachai, Kim, Jerome H., Michael, Nelson L., Zolla-Pazner, Susan, Santra, Sampa, Letvin, Norman L., Harrison, Stephen C., Haynes, Barton F.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2013
Onderwerpen:
Vaccines and Antiviral Agents
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3554162/
https://ncbi.nlm.nih.gov/pubmed/23175357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00718-12
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items